Journal Watch · Molecular Cell · 2026

Beyond prediction: The evolving role of artificial intelligence in genome editing.

This review discusses how AI is reshaping genome engineering, from gRNA activity prediction to the design of next-generation editors.

Shin S, Uhm H, Kim YW et al.Molecular Cell3 min readPharma relevance 50/100

DOI: 10.1016/j.molcel.2026.08.025PMID: 42880217Study type: review / perspective

TL;DR

This review discusses how AI is reshaping genome engineering, from gRNA activity prediction to the design of next-generation editors.

Key findings

  • Thus, AI-driven frameworks can now evolve genome-editing proteins, design molecular architectures, and generate de novo genome-editing enzymes.
  • This review discusses how AI is reshaping genome engineering, from gRNA activity prediction to the design of next-generation editors.

What they did

Early AI applications primarily addressed predictive tasks, including guide RNA (gRNA) activity, off-target effects, and editing outcomes for CRISPR-Cas nucleases, base editors, and prime editors. Recently, transformer-based protein language models (PLMs) and generative AI have expanded the role of AI beyond prediction to direct molecular design.

Full abstract (original)

Background: Since the discovery of the clustered regularly interspaced short palindromic repeat (CRISPR)-associated (Cas) system, genome-editing technologies have advanced rapidly, and the field has expanded substantially. In parallel, artificial intelligence (AI) has progressed at an unprecedented pace and is transforming genetic engineering.

What they did: Early AI applications primarily addressed predictive tasks, including guide RNA (gRNA) activity, off-target effects, and editing outcomes for CRISPR-Cas nucleases, base editors, and prime editors. Recently, transformer-based protein language models (PLMs) and generative AI have expanded the role of AI beyond prediction to direct molecular design.

Results & conclusions: Thus, AI-driven frameworks can now evolve genome-editing proteins, design molecular architectures, and generate de novo genome-editing enzymes. This review discusses how AI is reshaping genome engineering, from gRNA activity prediction to the design of next-generation editors.

Abstract © the authors / Molecular Cell (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1016/j.molcel.2026.08.025 · PubMed 42880217.

Why it matters for pharma & biotech

  • Directly relevant to teams in gene editing, AI in drug discovery / diagnostics — the abstract reports new data in that space, so competitive and pipeline teams should read the full text.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Modalities & themes detected: gene editing · AI in drug discovery / diagnostics

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • As a review, this paper synthesises prior studies rather than reporting new experimental data; weight it accordingly.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Molecular Cell study find?

This review discusses how AI is reshaping genome engineering, from gRNA activity prediction to the design of next-generation editors.

What type of study is this?

It is a review / perspective, published in Molecular Cell in 2026. Early AI applications primarily addressed predictive tasks, including guide RNA (gRNA) activity, off-target effects, and editing outcomes for CRISPR-Cas nucleases, base editors, and prime editors.

Where can I read the original paper?

The original is at the publisher via DOI 10.1016/j.molcel.2026.08.025. PubMed ID: 42880217. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Shin S, Uhm H, Kim YW et al.. Beyond prediction: The evolving role of artificial intelligence in genome editing.. Molecular Cell (2026). DOI: 10.1016/j.molcel.2026.08.025.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/beyond-prediction-the-evolving-role-of-artificial-intelligence-in-genome-608025/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides